テネシーにおける片頭痛の臨床試験
テネシー内の拠点で、片頭痛に関する8件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
Study of EVO756 in Adults With Migraine
- Campbell Clinical Research, Franklin
被験者募集中第2相
18歳〜64歳 · 全性別 · 2026/10/02更新 · NCT07616128MMA Embolization for Refractory Chronic Migraine
- Semmes Murphey Foundation, Memphis
被験者募集中
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT06735833A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Access Clinical Trials Inc /ID# 270280, Nashville
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/22更新 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
被験者募集中
10歳〜17歳 · 全性別 · 2026/09/21更新 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Vanderbilt Medical Center, Nashville
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/16更新 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Access Clinical Trials, Inc. /ID# 228002, Nashville
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/14更新 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Research Associates, Inc., Nashville
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/02更新 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- WR-ClinSearch, LLC, Chattanooga
- Access Clinical Trials, Inc, Nashville
- Clinical Research Associates, Inc., Nashville
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/20更新 · NCT07645924ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。